Cargando…
Molecular characterization of breast cancer needle core biopsy specimens by the 21‐gene Breast Recurrence Score test
BACKGROUND AND OBJECTIVE: Recent COVID‐19 pandemic guidelines recommend genomic assessment of core biopsies to help guide treatment decisions in estrogen receptor (ER)‐positive early‐stage breast cancer. Herein we characterize biopsy and excisional breast cancer specimens submitted for 21‐gene testi...
Autores principales: | Jakubowski, Debbie M., Bailey, Helen, Abran, John, Blacklock, Andrea, Ciau, Nancy, Mies, Carolyn, Tan, Vivian, Young, Rebekah, Lau, Anna, Baehner, Frederick L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496790/ https://www.ncbi.nlm.nih.gov/pubmed/32497318 http://dx.doi.org/10.1002/jso.26050 |
Ejemplares similares
-
Concordance of the 21-gene assay between core needle biopsy and resection specimens in early breast cancer patients
por: Qi, Peng, et al.
Publicado: (2021) -
The appropriate number of preoperative core needle biopsy specimens for analysis in breast cancer
por: Sun, Tao, et al.
Publicado: (2021) -
Needle core biopsy for breast lesions: An audit of 467 needle core biopsies
por: Radhakrishna, Selvi, et al.
Publicado: (2013) -
Accuracy of Estrogen and Progesterone Receptor Assessment in Core Needle Biopsy Specimens of Breast Cancer
por: Omranipour, Ramesh, et al.
Publicado: (2013) -
Adjunctive imprint cytology of core needle biopsy specimens improved diagnostic accuracy for breast cancer
por: Kashiwagi, Shinichiro, et al.
Publicado: (2013)